HZNP News and Press, Horizon Therapeutics Public Limited Company From 02/28/23

Summary Horizon Therapeutics Public Limited Company is a $25 billion biotech that's being acquired by Amgen Inc. The FTC has issued a 2nd request following a letter by Senator Elizabeth Warren. Warren raises a number of important issues but few that pertain specifically to this deal...

-- In 2023, 50 global patient advocacy groups will be eligible to receive a one-time, $5,000 grant -- -- Livestream with #RAREis Global Advocate Grant recipients discussing global challenges in rare disease to be held on Feb. 28 at 9:55 a.m. ET -- Horizon Therapeutics plc (Nasda...

More than 99% Horizon Therapeutics ( NASDAQ: HZNP ) shareholders who voted during a special meeting did so in favor of the company's acquisition by Amgen ( NASDAQ: AMGN ). That figure represented about 76% of total Horizon ( HZNP ) shares. The $28B acquisition is f...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Horizon Therapeutics plc (NASDAQ: HZNP): RECOMMENDED CA...

-- Analyses suggest the B-cell-depleting mechanism of UPLIZNA did not interfere with important immune activity, including COVID-19 infection defenses and antibody levels from childhood vaccines -- Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data from two post-hoc analyse...

Summary Amgen has seen a near 15% pullback since the Horizon acquisition was announced in December. This seems fair as shares had seen a strong performance beforehand, leverage is high, and the 2023 guidance is underwhelming. A recent pullback makes that the valuation looks fair, as...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Two billionaires –Paul Tudor Jones and George Soros — acquired shares of Horizon Therapeutics (NASDAQ: HZNP ) stock, a drugmaker, last quarter. On Dec. 12, Horizon agreed to be acquired by a giant pharmaceut...

Summary Form 13F filings show fund managers' top arbitrage stocks. Top M&A stocks of the 28 funds I follow. Horizon Therapeutics this quarter's top stock. These days merger arbitrage is a tale of two types. There are the deals with juicy spreads that seem to be a coin flip...

Summary We’re in the midst of the fourth quarter earnings season and already we’re seeing a cautionary setup for 2023 as corporations find ways to cut back. In the latter half of 2022 the number of companies announcing dividend decreases began to rise temporarily, before r...

Horizon Therapeutics ( NASDAQ: HZNP ) and Amgen ( NASDAQ: AMGN ) confirmed the companies received a "Second Request" from the Federal Trade Commission in regards to the planned almost $28 billion acquisition of the rare-disease focused company. Horizon fell 0.8% in after ...